Cetera Investment Advisers
IMNM icon

Cetera Investment Advisers’s Immunome IMNM Stock Holding History

Cetera Investment Advisers’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
12,019
+36
+0.3% +$770 ﹤0.01% 4294
2026
Q1 		$262K Sell
11,983
-2,022
-14% -$45K ﹤0.01% 4093
2025
Q4 		$301K Sell
14,005
-11,356
-45% -$199K ﹤0.01% 3904
2025
Q3 		$297K Buy
+25,361
New +$252K ﹤0.01% 3840
2024
Q4 		– Sell
-13,529
Closed -$198K – 3835
2024
Q3 		$198K Sell
13,529
-54,473
-80% -$774K ﹤0.01% 3385
2024
Q2 		$823K Sell
68,002
-55,096
-45% -$862K ﹤0.01% 2221
2024
Q1 		$3.04M Buy
+123,098
New +$2.5M 0.01% 1273

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Cetera Investment Advisers's IMNM Position: Q2 2026 in Review

Cetera Investment Advisers increased its Immunome (IMNM) stake by 0.3% in Q2 2026, buying an estimated $770 and bringing the position to 12,019 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #4294.

Cetera Investment Advisers first reported a position in IMNM in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.04M in Q1 2024. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Cetera Investment Advisers held 12,019 shares of Immunome worth $255K as of Q2 2026.
  • Cetera Investment Advisers bought 36 Immunome shares in Q2 2026, an estimated $770.
  • Immunome made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4294 holding.
  • Cetera Investment Advisers first reported a position in Immunome in Q1 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Immunome position peaked at $3.04M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.